APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crude Heparin

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.

Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

Selected research

Industry Growth & Trends

Global Crude Heparin Industry Growth and Trends Forecast to 2032

21 December 2025103 pages

Choose your research edition.

Industry ResearchCrude Heparin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Crude Heparin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Crude Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crude Heparin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Crude Heparin Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.

Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

Read the full market overview

The Top 5 manufacturers, Bioiberica, Shenzhen Hepalink, Nanjing King-friend, Sanofi and Fengrun Biological, held 56.28% of the market, in terms of revenue in 2019.

Report Scope

This report provides a structured, data-driven view of the global Crude Heparin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crude Heparin market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crude Heparin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toCrude Heparin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Crude Heparin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crude Heparin Market by Company

Bioiberica

Shenzhen Hepalink

Sanofi

Nanjing King-friend

Fengrun Biological Technology

Aspen Oss

Hebei Changshan Biochemical

Changzhou Qianhong

Hepac (Darling Ingredients)

Huaian MDC Pharmaceutical

Yantai Dongcheng Biochemicals

Crude Heparin Segment by Type

Pig Intestine Mucosa Heparin

Bovine Heparin and Others

Crude Heparin Segment by Application

Unfractionated Heparin (UFH)

Low-Molecular-Weight Heparin (LMWH)

Crude Heparin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crude Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crude Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crude Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Crude Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pig Intestine Mucosa Heparin Table 2. Major Company of Bovine Heparin and Others Table 3. Global Crude Heparin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Crude Heparin Sales by Type (2021-2026) & (t) Table 5. Global Crude Heparin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Crude Heparin Sales Market Share in Value by Type (2021-2026) Table 8. Global Crude Heparin Price by Type (2021-2026) & (USD/Kg) Table 9. Global Crude Heparin Sales by Type (2027-2032) & (t) Table 10. Global Crude Heparin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Crude Heparin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Crude Heparin Sales Market Share in Value by Type (2027-2032) Table 13. Global Crude Heparin Price by Type (2027-2032) & (USD/Kg) Table 14. North America Crude Heparin Sales by Type (2021-2026) & (t) Table 15. North America Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Crude Heparin Sales by Type (2021-2026) & (t) Table 17. Europe Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Crude Heparin Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Crude Heparin Sales by Type (2021-2026) & (t) Table 21. Latin America Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Crude Heparin Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Crude Heparin Sales by Type (2021-2026) & (US$ Million) Table 24. Crude Heparin Industry Trends Table 25. Crude Heparin Industry Drivers Table 26. Crude Heparin Industry Opportunities and Challenges Table 27. Crude Heparin Industry Restraints Table 28. Global Crude Heparin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Crude Heparin Revenue Market Share by Company (2021-2026) Table 30. Global Crude Heparin Sales by Company (2021-2026) & (t) Table 31. Global Crude Heparin Sales Share by Company (2021-2026) Table 32. Global Crude Heparin Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Crude Heparin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Crude Heparin Major Company Production Sites and Headquarters Table 35. Global Crude Heparin Company, Product Type & Application Table 36. Global Crude Heparin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Crude Heparin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Crude Heparin Sales by Region (2021-2026) & (t) Table 41. Global Crude Heparin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Crude Heparin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Crude Heparin Sales Market Share in Value by Region (2021-2026) Table 44. Global Crude Heparin Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Crude Heparin Sales by Region (2027-2032) & (t) Table 46. Global Crude Heparin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Crude Heparin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Crude Heparin Sales Market Share in Value by Region (2027-2032) Table 49. Global Crude Heparin Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Crude Heparin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Crude Heparin Sales by Application (2021-2026) & (t) Table 52. Global Crude Heparin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Crude Heparin Sales Market Share in Value by Application (2021-2026) Table 55. Global Crude Heparin Price by Application (2021-2026) & (USD/Kg) Table 56. Global Crude Heparin Sales by Application (2027-2032) & (t) Table 57. Global Crude Heparin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Crude Heparin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Crude Heparin Sales Market Share in Value by Application (2027-2032) Table 60. Global Crude Heparin Price by Application (2027-2032) & (USD/Kg) Table 61. North America Crude Heparin Sales by Application (2021-2026) & (t) Table 62. North America Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Crude Heparin Sales by Application (2021-2026) & (t) Table 64. Europe Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Crude Heparin Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Crude Heparin Sales by Application (2021-2026) & (t) Table 68. Latin America Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Crude Heparin Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Crude Heparin Sales by Application (2021-2026) & (US$ Million) Table 71. Bioiberica Company Information Table 72. Bioiberica Business Overview Table 73. Bioiberica Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Bioiberica Crude Heparin Product Portfolio Table 75. Bioiberica Recent Development Table 76. Shenzhen Hepalink Company Information Table 77. Shenzhen Hepalink Business Overview Table 78. Shenzhen Hepalink Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Shenzhen Hepalink Crude Heparin Product Portfolio Table 80. Shenzhen Hepalink Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Sanofi Crude Heparin Product Portfolio Table 85. Sanofi Recent Development Table 86. Nanjing King-friend Company Information Table 87. Nanjing King-friend Business Overview Table 88. Nanjing King-friend Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Nanjing King-friend Crude Heparin Product Portfolio Table 90. Nanjing King-friend Recent Development Table 91. Fengrun Biological Technology Company Information Table 92. Fengrun Biological Technology Business Overview Table 93. Fengrun Biological Technology Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Fengrun Biological Technology Crude Heparin Product Portfolio Table 95. Fengrun Biological Technology Recent Development Table 96. Aspen Oss Company Information Table 97. Aspen Oss Business Overview Table 98. Aspen Oss Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Aspen Oss Crude Heparin Product Portfolio Table 100. Aspen Oss Recent Development Table 101. Hebei Changshan Biochemical Company Information Table 102. Hebei Changshan Biochemical Business Overview Table 103. Hebei Changshan Biochemical Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Hebei Changshan Biochemical Crude Heparin Product Portfolio Table 105. Hebei Changshan Biochemical Recent Development Table 106. Changzhou Qianhong Company Information Table 107. Changzhou Qianhong Business Overview Table 108. Changzhou Qianhong Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Changzhou Qianhong Crude Heparin Product Portfolio Table 110. Changzhou Qianhong Recent Development Table 111. Hepac (Darling Ingredients) Company Information Table 112. Hepac (Darling Ingredients) Business Overview Table 113. Hepac (Darling Ingredients) Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Hepac (Darling Ingredients) Crude Heparin Product Portfolio Table 115. Hepac (Darling Ingredients) Recent Development Table 116. Huaian MDC Pharmaceutical Company Information Table 117. Huaian MDC Pharmaceutical Business Overview Table 118. Huaian MDC Pharmaceutical Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Huaian MDC Pharmaceutical Crude Heparin Product Portfolio Table 120. Huaian MDC Pharmaceutical Recent Development Table 121. Yantai Dongcheng Biochemicals Company Information Table 122. Yantai Dongcheng Biochemicals Business Overview Table 123. Yantai Dongcheng Biochemicals Crude Heparin Sales (t), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio Table 125. Yantai Dongcheng Biochemicals Recent Development Table 126. North America Crude Heparin Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 127. North America Crude Heparin Sales by Country (2021-2026) & (t) Table 128. North America Crude Heparin Sales Market Share by Country (2021-2026) Table 129. North America Crude Heparin Sales Forecast by Country (2027-2032) & (t) Table 130. North America Crude Heparin Sales Market Share Forecast by Country (2027-2032) Table 131. North America Crude Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Crude Heparin Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Crude Heparin Market Share by Country (2021-2026) Table 134. North America Crude Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Crude Heparin Market Share Forecast by Country (2027-2032) Table 136. Europe Crude Heparin Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 137. Europe Crude Heparin Sales by Country (2021-2026) & (t) Table 138. Europe Crude Heparin Sales Market Share by Country (2021-2026) Table 139. Europe Crude Heparin Sales Forecast by Country (2027-2032) & (t) Table 140. Europe Crude Heparin Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Crude Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Crude Heparin Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Crude Heparin Market Share by Country (2021-2026) Table 144. Europe Crude Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Crude Heparin Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Crude Heparin Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Crude Heparin Sales by Country (2021-2026) & (t) Table 148. Asia-Pacific Crude Heparin Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Crude Heparin Sales Forecast by Country (2027-2032) & (t) Table 150. Asia-Pacific Crude Heparin Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Crude Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Crude Heparin Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Crude Heparin Market Share by Country (2021-2026) Table 154. Asia-Pacific Crude Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Crude Heparin Market Share Forecast by Country (2027-2032) Table 156. Latin America Crude Heparin Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 157. Latin America Crude Heparin Sales by Country (2021-2026) & (t) Table 158. Latin America Crude Heparin Sales Market Share by Country (2021-2026) Table 159. Latin America Crude Heparin Sales Forecast by Country (2027-2032) & (t) Table 160. Latin America Crude Heparin Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Crude Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Crude Heparin Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Crude Heparin Market Share by Country (2021-2026) Table 164. Latin America Crude Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Crude Heparin Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Crude Heparin Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Crude Heparin Sales by Country (2021-2026) & (t) Table 168. Middle East and Africa Crude Heparin Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Crude Heparin Sales Forecast by Country (2027-2032) & (t) Table 170. Middle East and Africa Crude Heparin Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Crude Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Crude Heparin Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Crude Heparin Market Share by Country (2021-2026) Table 174. Middle East and Africa Crude Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Crude Heparin Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Crude Heparin Distributors List Table 179. Crude Heparin Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Crude Heparin Image Figure 2. Global Crude Heparin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crude Heparin Market Size (2021-2032) & (US$ Million) Figure 4. Global Crude Heparin Sales (2021-2032) & (t) Figure 5. Pig Intestine Mucosa Heparin Image Figure 6. Global Pig Intestine Mucosa Heparin Sales YoY Growth (2021-2032) & (t) Figure 7. Bovine Heparin and Others Image Figure 8. Global Bovine Heparin and Others Sales YoY Growth (2021-2032) & (t) Figure 9. Global Crude Heparin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Crude Heparin Market Share by Type 2025 VS 2032 Figure 11. North America Crude Heparin Sales Market Share in Volume by Type in 2025 Figure 12. North America Crude Heparin Sales Market Share in Value by Type in 2025 Figure 13. Europe Crude Heparin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Crude Heparin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Crude Heparin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Crude Heparin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Crude Heparin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Crude Heparin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Crude Heparin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Crude Heparin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Crude Heparin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Unfractionated Heparin (UFH) Image Figure 24. Global Unfractionated Heparin (UFH) Sales YoY Growth (2021-2032) & (t) Figure 25. Low-Molecular-Weight Heparin (LMWH) Image Figure 26. Global Low-Molecular-Weight Heparin (LMWH) Sales YoY Growth (2021-2032) & (t) Figure 27. Global Crude Heparin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Crude Heparin Market Share by Application 2025 VS 2032 Figure 29. North America Crude Heparin Sales Market Share in Volume by Application in 2025 Figure 30. North America Crude Heparin Sales Market Share in Value by Application in 2025 Figure 31. Europe Crude Heparin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Crude Heparin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Crude Heparin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Crude Heparin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Crude Heparin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Crude Heparin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Crude Heparin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Crude Heparin Sales Market Share in Value by Application in 2025 Figure 39. North America Crude Heparin Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 40. North America Crude Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Crude Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Crude Heparin Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. Europe Crude Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Crude Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Crude Heparin Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Asia-Pacific Crude Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Crude Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Crude Heparin Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Latin America Crude Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Crude Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Crude Heparin Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Middle East and Africa Crude Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Crude Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Crude Heparin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Crude Heparin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pig Intestine Mucosa Heparin
  • Bovine Heparin and Others
Applications
  • Unfractionated Heparin (UFH)
  • Low-Molecular-Weight Heparin (LMWH)
Companies covered
  • Bioiberica
  • Shenzhen Hepalink
  • Sanofi
  • Nanjing King-friend
  • Fengrun Biological Technology
  • Aspen Oss
  • Hebei Changshan Biochemical
  • Changzhou Qianhong
  • Hepac (Darling Ingredients)
  • Huaian MDC Pharmaceutical
  • Yantai Dongcheng Biochemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crude Heparin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Crude Heparin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Crude Heparin Market by Type
  6. 1.3.1 Pig Intestine Mucosa Heparin
  7. 1.3.2 Bovine Heparin and Others
  8. 1.4 Global Crude Heparin Market Size by Type
  9. 1.4.1 Global Crude Heparin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Crude Heparin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Crude Heparin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Crude Heparin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Crude Heparin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Crude Heparin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Crude Heparin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Crude Heparin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Crude Heparin Industry Trends
  2. 2.2 Crude Heparin Industry Drivers
  3. 2.3 Crude Heparin Industry Opportunities and Challenges
  4. 2.4 Crude Heparin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Crude Heparin Revenue (2021-2026)
  2. 3.2 Global Top Players by Crude Heparin Sales (2021-2026)
  3. 3.3 Global Top Players by Crude Heparin Price (2021-2026)
  4. 3.4 Global Crude Heparin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crude Heparin Major Company Production Sites & Headquarters
  6. 3.6 Global Crude Heparin Company, Product Type & Application
  7. 3.7 Global Crude Heparin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crude Heparin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crude Heparin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crude Heparin Tier 1, Tier 2, and Tier 3
4 Crude Heparin Regional Status and Outlook
  1. 4.1 Global Crude Heparin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Crude Heparin Historic Market Size by Region
  3. 4.2.1 Global Crude Heparin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Crude Heparin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Crude Heparin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Crude Heparin Forecasted Market Size by Region
  7. 4.3.1 Global Crude Heparin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Crude Heparin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Crude Heparin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crude Heparin by Application
  1. 5.1 Crude Heparin Market by Application
  2. 5.1.1 Unfractionated Heparin (UFH)
  3. 5.1.2 Low-Molecular-Weight Heparin (LMWH)
  4. 5.2 Global Crude Heparin Market Size by Application
  5. 5.2.1 Global Crude Heparin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Crude Heparin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Crude Heparin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Crude Heparin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Crude Heparin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Crude Heparin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Crude Heparin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Crude Heparin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bioiberica
  2. 6.1.1 Bioiberica Company Information
  3. 6.1.2 Bioiberica Business Overview
  4. 6.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bioiberica Crude Heparin Product Portfolio
  6. 6.1.5 Bioiberica Recent Developments
  7. 6.2 Shenzhen Hepalink
  8. 6.2.1 Shenzhen Hepalink Company Information
  9. 6.2.2 Shenzhen Hepalink Business Overview
  10. 6.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Hepalink Crude Heparin Product Portfolio
  12. 6.2.5 Shenzhen Hepalink Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Crude Heparin Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Nanjing King-friend
  20. 6.4.1 Nanjing King-friend Company Information
  21. 6.4.2 Nanjing King-friend Business Overview
  22. 6.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanjing King-friend Crude Heparin Product Portfolio
  24. 6.4.5 Nanjing King-friend Recent Developments
  25. 6.5 Fengrun Biological Technology
  26. 6.5.1 Fengrun Biological Technology Company Information
  27. 6.5.2 Fengrun Biological Technology Business Overview
  28. 6.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fengrun Biological Technology Crude Heparin Product Portfolio
  30. 6.5.5 Fengrun Biological Technology Recent Developments
  31. 6.6 Aspen Oss
  32. 6.6.1 Aspen Oss Company Information
  33. 6.6.2 Aspen Oss Business Overview
  34. 6.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aspen Oss Crude Heparin Product Portfolio
  36. 6.6.5 Aspen Oss Recent Developments
  37. 6.7 Hebei Changshan Biochemical
  38. 6.7.1 Hebei Changshan Biochemical Company Information
  39. 6.7.2 Hebei Changshan Biochemical Business Overview
  40. 6.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hebei Changshan Biochemical Crude Heparin Product Portfolio
  42. 6.7.5 Hebei Changshan Biochemical Recent Developments
  43. 6.8 Changzhou Qianhong
  44. 6.8.1 Changzhou Qianhong Company Information
  45. 6.8.2 Changzhou Qianhong Business Overview
  46. 6.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Changzhou Qianhong Crude Heparin Product Portfolio
  48. 6.8.5 Changzhou Qianhong Recent Developments
  49. 6.9 Hepac (Darling Ingredients)
  50. 6.9.1 Hepac (Darling Ingredients) Company Information
  51. 6.9.2 Hepac (Darling Ingredients) Business Overview
  52. 6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Portfolio
  54. 6.9.5 Hepac (Darling Ingredients) Recent Developments
  55. 6.10 Huaian MDC Pharmaceutical
  56. 6.10.1 Huaian MDC Pharmaceutical Company Information
  57. 6.10.2 Huaian MDC Pharmaceutical Business Overview
  58. 6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio
  60. 6.10.5 Huaian MDC Pharmaceutical Recent Developments
  61. 6.11 Yantai Dongcheng Biochemicals
  62. 6.11.1 Yantai Dongcheng Biochemicals Company Information
  63. 6.11.2 Yantai Dongcheng Biochemicals Business Overview
  64. 6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
  66. 6.11.5 Yantai Dongcheng Biochemicals Recent Developments
7 North America by Country
  1. 7.1 North America Crude Heparin Sales by Country
  2. 7.1.1 North America Crude Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Crude Heparin Sales by Country (2021-2026)
  4. 7.1.3 North America Crude Heparin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Crude Heparin Market Size by Country
  6. 7.2.1 North America Crude Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Crude Heparin Market Size by Country (2021-2026)
  8. 7.2.3 North America Crude Heparin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Crude Heparin Sales by Country
  2. 8.1.1 Europe Crude Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Crude Heparin Sales by Country (2021-2026)
  4. 8.1.3 Europe Crude Heparin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Crude Heparin Market Size by Country
  6. 8.2.1 Europe Crude Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Crude Heparin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Crude Heparin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Crude Heparin Sales by Country
  2. 9.1.1 Asia-Pacific Crude Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Crude Heparin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Crude Heparin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Crude Heparin Market Size by Country
  6. 9.2.1 Asia-Pacific Crude Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Crude Heparin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Crude Heparin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Crude Heparin Sales by Country
  2. 10.1.1 South America Crude Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Crude Heparin Sales by Country (2021-2026)
  4. 10.1.3 South America Crude Heparin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Crude Heparin Market Size by Country
  6. 10.2.1 South America Crude Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Crude Heparin Market Size by Country (2021-2026)
  8. 10.2.3 South America Crude Heparin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Crude Heparin Sales by Country
  2. 11.1.1 Middle East and Africa Crude Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Crude Heparin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Crude Heparin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Crude Heparin Market Size by Country
  6. 11.2.1 Middle East and Africa Crude Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Crude Heparin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Crude Heparin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Crude Heparin Value Chain Analysis
  2. 12.1.1 Crude Heparin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Crude Heparin Production Mode & Process
  7. 12.2 Crude Heparin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Crude Heparin Distributors
  10. 12.2.3 Crude Heparin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst